193 related articles for article (PubMed ID: 35289746)
1. The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant
Fernández Álvaro E; Voong Vinh P; de Cozar C; Willé DR; Urones B; Cortés A; Price A; Tran Do Hoang N; Ha Thanh T; McCloskey M; Shaheen S; Dayao D; Martinot A; de Mercado J; Castañeda P; García-Perez A; Singa B; Pavlinac P; Walson J; Martínez-Martínez MS; Arnold SLM; Tzipori S; Ballell Pages L; Baker S
Elife; 2022 Mar; 11():. PubMed ID: 35289746
[TBL] [Abstract][Full Text] [Related]
2. Tebipenem as an oral alternative for the treatment of typhoid caused by XDR Salmonella Typhi.
Mylona E; Voong Vinh P; Qureshi S; Karkey A; Dongol S; Ha Thanh T; Walson J; Ballell L; Fernández Álvaro E; Qamar F; Baker S
J Antimicrob Chemother; 2021 Nov; 76(12):3197-3200. PubMed ID: 34534310
[TBL] [Abstract][Full Text] [Related]
3. Tebipenem pivoxil hydrobromide-No PICC, no problem!
Sodhi V; Kronsberg KA; Clark M; Cho JC
Pharmacotherapy; 2021 Sep; 41(9):748-761. PubMed ID: 34370326
[TBL] [Abstract][Full Text] [Related]
4. Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial.
Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
Lancet Microbe; 2024 Apr; 5(4):e355-e365. PubMed ID: 38432233
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
6. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
Eckburg PB; Muir L; Critchley IA; Walpole S; Kwak H; Phelan AM; Moore G; Jain A; Keutzer T; Dane A; Melnick D; Talley AK
N Engl J Med; 2022 Apr; 386(14):1327-1338. PubMed ID: 35388666
[TBL] [Abstract][Full Text] [Related]
7.
Cotroneo N; Rubio A; Critchley IA; Pillar C; Pucci MJ
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423950
[TBL] [Abstract][Full Text] [Related]
8. Correction: The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant
Fernández Álvaro E; Voong Vinh P; de Cozar C; Willé DR; Urones B; Cortés A; Price A; Tran Do Hoang N; Ha Thanh T; McCloskey M; Shaheen S; Dayao D; Martinot A; de Mercado J; Castañeda P; García-Perez A; Singa B; Pavlinac P; Walson J; Martínez-Martínez MS; Arnold SLM; Tzipori S; Pages LB; Baker S
Elife; 2022 Sep; 11():. PubMed ID: 36063387
[No Abstract] [Full Text] [Related]
9. Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
McEntee L; Johnson A; Farrington N; Unsworth J; Dane A; Jain A; Cotroneo N; Critchley I; Melnick D; Parr T; Ambrose PG; Das S; Hope W
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109982
[TBL] [Abstract][Full Text] [Related]
10. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial activity of tebipenem against various clinical isolates from various specimen, mainly urinary tract].
Muratani T; Doi K; Kobayashi T; Nakamura T; Matsumoto T
Jpn J Antibiot; 2009 Apr; 62(2):116-26. PubMed ID: 19673353
[TBL] [Abstract][Full Text] [Related]
12. Characterization of SPR994, an Orally Available Carbapenem, with Activity Comparable to Intravenously Administered Carbapenems.
Rubio A; Pucci MJ; Jain A
ACS Infect Dis; 2018 Oct; 4(10):1436-1438. PubMed ID: 30118209
[TBL] [Abstract][Full Text] [Related]
13. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and drug resistance patterns of Gram-negative enteric bacterial pathogens from diarrheic patients in Ethiopia: A systematic review and meta-analysis.
Beyene AM; Gezachew M; Mengesha D; Yousef A; Gelaw B
PLoS One; 2022; 17(3):e0265271. PubMed ID: 35294487
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activity of tebipenem against ESBL-producing E. coli.
Thamlikitkul V; Lorchirachoonkul N; Tiengrim S
J Med Assoc Thai; 2014 Dec; 97(12):1259-68. PubMed ID: 25764632
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, against a Global Set of Enterobacteriaceae Isolates, Including a Challenge Set of Organisms.
Arends SJR; Rhomberg PR; Cotroneo N; Rubio A; Flamm RK; Mendes RE
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936096
[TBL] [Abstract][Full Text] [Related]
17. Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media.
Sugita R
J Infect Chemother; 2013 Jun; 19(3):465-71. PubMed ID: 23393013
[TBL] [Abstract][Full Text] [Related]
18. Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil.
Sakata H; Kuroki H; Ouchi K; Tajima T; Iwata S;
J Infect Chemother; 2017 May; 23(5):307-311. PubMed ID: 28238680
[TBL] [Abstract][Full Text] [Related]
19. Investigations on yearly changes in tebipenem susceptibility of bacterial isolates from pediatric patients -A post-marketing surveillance of tebipenem pivoxil granules for pediatric.
Sugano T; Takata T; Senju N; Takayama Y; Ida T
Jpn J Antibiot; 2016 Aug; 69(4):265-290. PubMed ID: 30226954
[TBL] [Abstract][Full Text] [Related]
20. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
